{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:31:10Z","timestamp":1793298670282,"version":"4.5.0"},"reference-count":88,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T00:00:00Z","timestamp":1701907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Carbapenem-resistant <jats:italic>Enterobacterales<\/jats:italic> (CRE) are spreading in the United Arab Emirates (UAE) where their dissemination is facilitated by international travel, trade, and tourism. The objective of this study is to describe the longitudinal changes of CRE as reported by the national AMR surveillance system of the UAE.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this study, we retrospectively describe CRE isolated from 317 surveillance sites, including 87 hospitals and 230 centers\/clinics from 2010 to 2021. The associated clinical, demographic, and microbiological characteristics are presented by relying on the UAE national AMR surveillance program. Data was analyzed using WHONET microbiology laboratory database software (<jats:ext-link>http:\/\/www.whonet.org<\/jats:ext-link>).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 14,593 carbapenem resistant <jats:italic>Enterobacterales<\/jats:italic> were analyzed, of which 48.1% were carbapenem resistant <jats:italic>Klebsiella pneumoniae<\/jats:italic> (CRKp), 25.1% carbapenem resistant <jats:italic>Escherichia coli<\/jats:italic> (CREc), and 26.8% represented 72 other carbapenem resistant species. Carbapenem resistant strains were mostly associated with adults and isolated from urine samples (36.9% of CRKp and 66.6% of CREc) followed by respiratory samples (26.95% for CRKp) and soft tissue samples (19.5% for CRKp). Over the studied period carbapenem resistance rates remained high, especially in <jats:italic>K. pneumoniae<\/jats:italic>, and in 2021 were equivalent to 67.6% for imipenem, 76.2% for meropenem, and 91.6% for ertapenem. Nevertheless, there was a statistically significant decreasing trend for imipenem and meropenem resistance in <jats:italic>Klebsiella species<\/jats:italic> (<jats:italic>p<\/jats:italic> &amp;lt; 0.01) while the decrease in ertapenem resistance was non-significant. Concerning <jats:italic>E. coli<\/jats:italic>, there was a statistically significant decreasing trend for meropenem and imipenem resistance over the 12 years, while ertapenem resistance increased significantly with 83.8% of <jats:italic>E. coli<\/jats:italic> exhibiting ertapenem resistance in 2021. Resistance rates to ceftazidime and cefotaxime remained higher than 90% (in 2021) for CRKp and cefotaxime rates increased to 90.5% in 2021 for CREc. Starting 2014, resistance to colistin and tigecycline was observed in carbapenem resistant <jats:italic>Enterobacterales<\/jats:italic>. CRE were associated with a higher mortality (RR: 6.3), admission to ICU (RR 3.9), and increased length of stay (LOS; 10 excess inpatient days per CRE case).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study supports the need to monitor CRE in the UAE and draws attention to the significant increase of ertapenem resistance in <jats:italic>E. coli<\/jats:italic>. Future surveillance analysis should include a genetic description of carbapenem resistance to provide new strategies.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2023.1244482","type":"journal-article","created":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T05:36:12Z","timestamp":1702013772000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Carbapenem resistant Enterobacterales in the United Arab Emirates: a retrospective analysis from 2010 to 2021"],"prefix":"10.3389","volume":"11","author":[{"given":"Jens","family":"Thomsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najiba M.","family":"Abdulrazzaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The UAE AMR Surveillance Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean B.","family":"Everett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Godfred Antony","family":"Menezes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abiola","family":"Senok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Ayoub Moubareck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,12,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.3390\/antibiotics11091263","article-title":"Epidemiology, mechanisms of resistance and treatment algorithm for infections due to carbapenem-resistant gram-negative bacteria: an expert panel opinion","volume":"11","author":"Coppola","year":"2022","journal-title":"Antibiotics"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.3390\/medicina58111675","article-title":"An Overview on phenotypic and genotypic characterisation of carbapenem-resistant enterobacterales","volume":"58","author":"Rabaan","year":"2022","journal-title":"Medicina"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1007\/s10096-021-04296-1","article-title":"Treatment for carbapenem-resistant Enterobacterales infections: recent advances and future directions","volume":"40","author":"Tompkins","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"eabe9805","DOI":"10.1126\/scitranslmed.abe9805","article-title":"Imaging Enterobacterales infections in patients using pathogen-specific positron emission tomography","volume":"13","author":"Ordonez","year":"2021","journal-title":"Sci Transl Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.cmi.2021.12.008","article-title":"Seven-versus 14-day course of antibiotics for the treatment of bloodstream infections by Enterobacterales: a randomized, controlled trial","volume":"28","author":"Molina","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1093\/jac\/dkac239","article-title":"Characteristics of community-acquired carbapenem-resistant Enterobacterales","volume":"77","author":"Shrestha","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e0235921","DOI":"10.1128\/spectrum.02359-21","article-title":"Impact of empirical antibiotic therapy on outcomes of outpatient urinary tract infection due to nonsusceptible Enterobacterales","volume":"10","author":"Dunne","year":"2022","journal-title":"Microbiol Spectr"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.jmii.2021.07.007","article-title":"Distribution of \u03b2-lactamases and emergence of carbapenemases co-occurring Enterobacterales isolates with high-level antibiotic resistance identified from patients with intra-abdominal infection in the Asia-Pacific region, 2015-2018","volume":"55","author":"Chen","year":"2022","journal-title":"J Microbiol Immunol Infect"},{"key":"B9","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3389\/fphar.2019.00262","article-title":"Molecular epidemiology and risk factors of ventilator-associated pneumonia infection caused by carbapenem-resistant Enterobacteriaceae","volume":"10","author":"Gao","year":"2019","journal-title":"Front Pharmacol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/14787210.2018.1436966","article-title":"Management of infections caused by extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae: current evidence and future prospects","volume":"16","author":"Sheu","year":"2018","journal-title":"Expert Rev Anti Infect Ther"},{"key":"B11","unstructured":"CRE | HAI | CDC [Internet].2021"},{"key":"B12","doi-asserted-by":"publisher","first-page":"E186","DOI":"10.3390\/antibiotics9040186","article-title":"The current burden of Carbapenemases: review of significant properties and dissemination among gram-negative bacteria","volume":"9","author":"Hammoudi Halat","year":"2020","journal-title":"Antibiotics"},{"key":"B13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.medmal.2013.11.007","article-title":"Carbapenemase-producing Enterobacteriaceae: overview of a major public health challenge","volume":"44","author":"Nordmann","year":"2014","journal-title":"Med Mal Infect."},{"key":"B14","doi-asserted-by":"publisher","first-page":"101871","DOI":"10.1016\/j.eclinm.2023.101871","article-title":"Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control-control study (EURECA)","volume":"57","author":"P\u00e9rez-Galera","year":"2023","journal-title":"eClinicalMedicine."},{"key":"B15","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1097\/QCO.0000000000000608","article-title":"Epidemiology of carbapenem-resistant gram-negative infections globally","volume":"32","author":"Brink","year":"2019","journal-title":"Curr Opin Infect Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.3390\/antibiotics11101435","article-title":"Early years of carbapenem-resistant Enterobacterales epidemic in Abu Dhabi","volume":"11","author":"P\u00e1l","year":"2022","journal-title":"Antibiotics"},{"key":"B18","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.jgar.2022.06.019","article-title":"Clinical epidemiology of carbapenem-resistant Enterobacterales in the Greater Houston region of Texas: a 6-year trend and surveillance analysis","volume":"30","author":"Tadese","year":"2022","journal-title":"J Glob Antimicrob Resist"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13756-019-0639-7","article-title":"Epidemiology of Carbapenem-resistant Enterobacteriaceae in Egyptian intensive care units using National Healthcare-associated Infections Surveillance Data, 2011-2017","volume":"9","author":"Kotb","year":"2020","journal-title":"Antimicrob Resist Infect Control"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1093\/jac\/dkw242","article-title":"Rise and fall of KPC-producing Klebsiella pneumoniae in New York City","volume":"71","author":"Abdallah","year":"2016","journal-title":"J Antimicrob Chemother."},{"key":"B21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1556\/030.65.2018.005","article-title":"Genetic support of carbapenemases in double carbapenemase producer Klebsiella pneumoniae isolated in the Arabian Peninsula","volume":"65","author":"Al-Baloushi","year":"2018","journal-title":"Acta Microbiol Immunol Hung."},{"key":"B22","unstructured":""},{"key":"B23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ijid.2022.04.034","article-title":"The first nationwide surveillance of carbapenem-resistant Enterobacterales in the United Arab Emirates - increased association of Klebsiella pneumoniae CC14 clone with Emirati patients","volume":"120","author":"Sonnevend","year":"2022","journal-title":"Int J Infect Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ijantimicag.2018.03.003","article-title":"Clonal emergence of Klebsiella pneumoniae ST14 co-producing OXA-48-type and NDM carbapenemases with high rate of colistin resistance in Dubai, United Arab Emirates","volume":"52","author":"Moubareck","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1099\/jmm.0.059014-0","article-title":"Emergence and spread of NDM-1 producer Enterobacteriaceae with contribution of IncX3 plasmids in the United Arab Emirates","volume":"62","author":"Sonnevend","year":"2013","journal-title":"J Med Microbiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e00418","DOI":"10.1128\/AAC.00418-17","article-title":"Multihospital occurrence of pan-resistant Klebsiella pneumoniae sequence type 147 with an ISEcp1-directed blaOXA-181 insertion in the mgrB gene in the United Arab Emirates","volume":"61","author":"Sonnevend","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1247627","DOI":"10.3389\/fpubh.2023.1247627","article-title":"Surveillance of antimicrobial resistance in the United Emirates: the early implementation phase","volume":"11","author":"Thomsen","year":"2023","journal-title":"Front Public Health"},{"key":"B28","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing","year":"2020"},{"key":"B29","unstructured":"2022"},{"key":"B30","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"B31","doi-asserted-by":"publisher","first-page":"dlac060","DOI":"10.1093\/jacamr\/dlac060","article-title":"Carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa causing infection in Africa and the Middle East: a surveillance study from the ATLAS programme (2018-20)","volume":"4","author":"Karlowsky","year":"2022","journal-title":"JAC Antimicrob Resist"},{"key":"B32","first-page":"125","article-title":"A reflection on bacterial resistance to antimicrobial agents at a major tertiary care center in Lebanon over a decade","volume":"60","author":"Araj","year":"2012","journal-title":"J Med Liban"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.3390\/antibiotics11101295","article-title":"Prevalence and molecular mechanisms of Carbapenem resistance among gram-negative bacilli in three hospitals of Northern Lebanon","volume":"11","author":"Rima","year":"2022","journal-title":"Antibiotics"},{"key":"B34","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ijid.2015.04.011","article-title":"Susceptibility trends and molecular characterization of Gram-negative bacilli associated with urinary tract and intra-abdominal infections in Jordan and Lebanon: SMART 2011-2013","volume":"35","author":"Hayajneh","year":"2015","journal-title":"Int J Infect Dis"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1089\/mdr.2017.0238","article-title":"Characterization of Carbapenemase-producing Enterobacteriaceae from patients in Amman, Jordan","volume":"24","author":"Aqel","year":"2018","journal-title":"Microb Drug Resist"},{"key":"B36","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/S0924-8579(12)70003-1","article-title":"Impact of revised CLSI breakpoints for susceptibility to third-generation cephalosporins and carbapenems among Enterobacteriaceae isolates in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2002-2010","volume":"40","author":"Huang","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.2147\/IDR.S299846","article-title":"Antimicrobial surveillance for bacterial uropathogens in Ha'il, Saudi Arabia: a five-year multicenter retrospective study","volume":"14","author":"Bazaid","year":"2021","journal-title":"Infect Drug Resist"},{"key":"B38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4103\/JLP.JLP_101_18","article-title":"Epidemiology of carbapenem-resistant Enterobacteriaceae in a tertiary care center in the kingdom of Bahrain","volume":"11","author":"Saeed","year":"2019","journal-title":"J Lab Phys"},{"key":"B39","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ajic.2021.09.018","article-title":"Impact of the COVID-19 pandemic on the incidence of multidrug-resistant bacterial infections in an acute care hospital in Brazil","volume":"50","author":"Polly","year":"2021","journal-title":"Am J Infect Control"},{"key":"B40","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.jiph.2022.12.022","article-title":"Impact of COVID-19 pandemic on multidrug resistant gram positive and gram negative pathogens: a systematic review","volume":"16","author":"Abubakar","year":"2023","journal-title":"J Infect Public Health"},{"key":"B41","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3390\/life11030220","article-title":"Implications of COVID-19 pandemic on the emergence of antimicrobial resistance: adjusting the response to future outbreaks","volume":"11","author":"Rusic","year":"2021","journal-title":"Life"},{"key":"B42","doi-asserted-by":"publisher","first-page":"823626","DOI":"10.3389\/fcimb.2022.823626","article-title":"The collateral effects of COVID-19 pandemic on the status of Carbapenemase-producing pathogens","volume":"12","author":"Ayoub Moubareck","year":"2022","journal-title":"Front Cell Infect Microbiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"601968","DOI":"10.3389\/fcimb.2021.601968","article-title":"Carbapenem-resistant Enterobacterales in long-term care facilities: a global and narrative review","volume":"11","author":"Chen","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"942","DOI":"10.3390\/antibiotics11070942","article-title":"A retrospective study of risk factors, mortality, and treatment outcomes for infections with Carbapenemase-producing Enterobacterales in a Tertiary Hospital in Havana, Cuba","volume":"11","author":"Yu","year":"2022","journal-title":"Antibiotics"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.3855\/jidc.17003","article-title":"Molecular typing and drug resistance analysis of carbapenem-resistant Klebsiella pneumoniae from paediatric patients in China","volume":"16","author":"Zhang","year":"2022","journal-title":"J Infect Dev Ctries"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.2147\/IDR.S175584","article-title":"Resistance phenotype and clinical molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae among pediatric patients in Shanghai","volume":"11","author":"Tian","year":"2018","journal-title":"Infect Drug Resist"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s13312-017-1204-1","article-title":"Carbapenem-resistant Enterobacteriaceae in pediatric bloodstream infections in rural Southern India","volume":"54","author":"Sekar","year":"2017","journal-title":"Indian Pediatr"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.3201\/eid2111.150548","article-title":"Carbapenem-resistant Enterobacteriaceae in children, United States, 1999-2012","volume":"21","author":"Logan","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"B49","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1093\/jpids\/piz085","article-title":"Treatment of Carbapenem-resistant Enterobacteriaceae infections in children","volume":"9","author":"Chiotos","year":"2019","journal-title":"J Pediatric Infect Dis Soc"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1038\/s41598-021-82166-8","article-title":"Increasing New Delhi metallo-\u03b2-lactamase-positive Escherichia coli among carbapenem non-susceptible Enterobacteriaceae in Taiwan during 2016 to 2018","volume":"11","author":"Huang","year":"2021","journal-title":"Sci Rep."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01882-17","article-title":"Epidemiology of Carbapenem-resistant Enterobacteriaceae infections: report from the China CRE network","author":"Zhang","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"B52","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jmii.2014.05.010","article-title":"Clinical features of patients with carbapenem nonsusceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: a nationwide multicenter study in Taiwan","volume":"48","author":"Chang","year":"2015","journal-title":"J Microbiol Immunol Infect"},{"key":"B53","doi-asserted-by":"publisher","first-page":"S196","DOI":"10.1093\/cid\/ciy660","article-title":"Phenotypic and genotypic characterization of carbapenem-resistant Enterobacteriaceae: data from a longitudinal large-scale CRE study in China (2012\u20132016)","volume":"67","author":"Wang","year":"2018","journal-title":"Clin Infect Dis"},{"key":"B54","doi-asserted-by":"publisher","first-page":"737828","DOI":"10.3389\/fmicb.2021.737828","article-title":"Preponderance of bla KPC-carrying carbapenem-resistant Enterobacterales among fecal isolates from community food handlers in Kuwait","volume":"12","author":"Moghnia","year":"2021","journal-title":"Front Microbiol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"867","DOI":"10.18388\/abp.2015_1148","article-title":"Klebsiella pneumoniae: characteristics of carbapenem resistance and virulence factors","volume":"62","author":"Candan","year":"2015","journal-title":"Acta Biochim Pol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1080\/22221751.2020.1799721","article-title":"Prevalence, risk factors and molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae in patients from Zhejiang, China, 2008-2018","volume":"9","author":"Hu","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"B57","doi-asserted-by":"publisher","first-page":"991306","DOI":"10.3389\/fpubh.2022.991306","article-title":"Hypervirulent carbapenem-resistant Klebsiella pneumoniae causing highly fatal meningitis in southeastern China","volume":"10","author":"Huang","year":"2022","journal-title":"Front Public Health"},{"key":"B58","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1099\/jmm.0.001482","article-title":"Surveillance of carbapenem-resistant Klebsiella pneumoniae in a paediatric hospital in China revealed the dynamics of carbapenemase and the prevalence of ST2735 K. pneumoniae","author":"Zhou","year":"2022","journal-title":"J Med Microbiol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e0095722","DOI":"10.1128\/spectrum.00957-22","article-title":"Genomic surveillance of carbapenem-resistant Klebsiella pneumoniae from a major public health hospital in Singapore","volume":"10","author":"Teo","year":"2022","journal-title":"Microbiol Spectr"},{"key":"B60","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s00284-018-1475-3","article-title":"Tracking multidrug-resistant Klebsiella pneumoniae from an Italian Hospital: molecular epidemiology and surveillance by PFGE, RAPD and PCR-based resistance genes prevalence","volume":"75","author":"Ripabelli","year":"2018","journal-title":"Curr Microbiol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13756-018-0362-9","article-title":"Carbapenem non-susceptibility of Klebsiella pneumoniae isolates in hospitals from 2011 to 2016, data from the German Antimicrobial Resistance Surveillance (ARS)","volume":"7","author":"Koppe","year":"2018","journal-title":"Antimicrob Resist Infect Control."},{"key":"B62","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3390\/antibiotics12020234","article-title":"Carbapenem-resistant Klebsiella pneumoniae: virulence factors, molecular epidemiology and latest updates in treatment options","volume":"12","author":"Karampatakis","year":"2023","journal-title":"Antibiotics"},{"key":"B63","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fmicb.2019.00080","article-title":"Infections caused by carbapenem-resistant Enterobacteriaceae: an update on therapeutic options","volume":"10","author":"Sheu","year":"2019","journal-title":"Front Microbiol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1089\/mdr.2021.0010","article-title":"Antimicrobial resistance trends of Escherichia coli isolates from outpatient and inpatient urinary infections over a 20-year period","volume":"28","author":"Milano","year":"2022","journal-title":"Microb Drug Resist"},{"key":"B65","doi-asserted-by":"publisher","first-page":"101019","DOI":"10.1016\/j.nmni.2022.101019","article-title":"Carbapenem resistance associated with coliuria among outpatient and hospitalised urology patients","volume":"48","author":"Adegoke","year":"2022","journal-title":"New Microbes New Infect."},{"key":"B66","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.3390\/microorganisms10112283","article-title":"Characterization of genomic diversity among Carbapenem-resistant Escherichia coli clinical isolates and antibacterial efficacy of silver nanoparticles from Pakistan","volume":"10","author":"Gondal","year":"2022","journal-title":"Microorganisms."},{"key":"B67","doi-asserted-by":"publisher","first-page":"813145","DOI":"10.3389\/fmicb.2021.813145","article-title":"Urinary tract infection etiological profiles and antibiotic resistance patterns varied among different age categories: a retrospective study from a tertiary general hospital during a 12-year period","volume":"12","author":"Huang","year":"2021","journal-title":"Front Microbiol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"6413","DOI":"10.2147\/IDR.S384515","article-title":"Analysis of the distribution and drug resistance of pathogens in patients with urinary tract infection in the Eastern Chongming area of Shanghai from 2018 to 2020","volume":"15","author":"Li","year":"2022","journal-title":"Infect Drug Resist"},{"key":"B69","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrmicro3432","article-title":"Urinary tract infections: epidemiology, mechanisms of infection and treatment options","volume":"13","author":"Flores-Mireles","year":"2015","journal-title":"Nat Rev Microbiol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1067\/mda.2003.7","article-title":"Epidemiology of urinary tract infections: incidence, morbidity, and economic costs","volume":"49","author":"Foxman","year":"2003","journal-title":"Dis Mon"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1056\/NEJMcp1104429","article-title":"Clinical practice. Uncomplicated urinary tract infection","volume":"366","author":"Hooton","year":"2012","journal-title":"N Engl J Med."},{"key":"B72","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1080\/1120009X.2017.1380395","article-title":"Multi-drug-resistant Gram-negative bacteria causing urinary tract infections: a review","volume":"29","author":"Mazzariol","year":"2017","journal-title":"J Chemother"},{"key":"B73","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jgar.2021.08.005","article-title":"Phenotypic and genotypic characterisation of cephalosporin-, carbapenem- and colistin-resistant Gram-negative bacterial pathogens in Lebanon, Jordan and Iraq","volume":"27","author":"Moghnieh","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"key":"B74","doi-asserted-by":"publisher","first-page":"e2137277","DOI":"10.1001\/jamanetworkopen.2021.37277","article-title":"Effectiveness of fosfomycin for the treatment of multidrug-resistant Escherichia coli bacteremic urinary tract infections: a randomized clinical trial","volume":"5","author":"Sojo-Dorado","year":"2022","journal-title":"JAMA Netw Open."},{"key":"B75","first-page":"45","article-title":"Fosfomycin in infections caused by multidrug-resistant Gram-negative pathogens","volume":"32","author":"Ruiz Ramos","year":"2019","journal-title":"Rev Esp Quimioter"},{"key":"B76","doi-asserted-by":"publisher","first-page":"e00779","DOI":"10.1128\/AAC.00779-19","article-title":"Evaluation of the synergy of ceftazidime-avibactam in combination with meropenem, amikacin, aztreonam, colistin, or fosfomycin against well-characterized multidrug-resistant Klebsiella pneumoniae and Pseudomonas aeruginosa","volume":"63","author":"Mikhail","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01911-20","article-title":"Interplay among different fosfomycin resistance mechanisms in Klebsiella pneumoniae","author":"Ortiz-Padilla","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"B78","doi-asserted-by":"publisher","first-page":"9175","DOI":"10.3390\/ijms23169175","article-title":"Resensitization of fosfomycin-resistant Escherichia coli using the CRISPR system","volume":"23","author":"Walflor","year":"2022","journal-title":"Int J Mol Sci."},{"key":"B79","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ijantimicag.2018.09.013","article-title":"Resistance to fosfomycin: mechanisms, frequency and clinical consequences","volume":"53","author":"Falagas","year":"2019","journal-title":"Int J Antimicrob Agents."},{"key":"B80","doi-asserted-by":"publisher","first-page":"e0015221","DOI":"10.1128\/Spectrum.00152-21","article-title":"Combined effect of polymyxin B and tigecycline to overcome heteroresistance in carbapenem-resistant Klebsiella pneumoniae","volume":"9","author":"Tian","year":"2021","journal-title":"Microbiol Spectr"},{"key":"B81","doi-asserted-by":"publisher","first-page":"622","DOI":"10.21037\/apm.2019.09.11","article-title":"Tigecycline in combination with other antibiotics against clinical isolates of carbapenem-resistant Klebsiella pneumoniae in vitro","volume":"8","author":"Zhang","year":"2019","journal-title":"Ann Palliat Med"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/s41564-019-0496-4","article-title":"Plasmid-encoded tet(X) genes that confer high-level tigecycline resistance in Escherichia coli","volume":"4","author":"Sun","year":"2019","journal-title":"Nat Microbiol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1900340","DOI":"10.2807\/1560-7917.ES.2019.24.25.1900340","article-title":"Detection of plasmid-mediated tigecycline-resistant gene tet(X4) in Escherichia coli from pork, Sichuan and Shandong Provinces, China, February 2019","volume":"24","author":"Bai","year":"2019","journal-title":"Euro Surveill"},{"key":"B84","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/jac\/dkz450","article-title":"Tigecycline-non-susceptible hypervirulent Klebsiella pneumoniae strains in Taiwan","volume":"75","author":"Cheng","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"B85","doi-asserted-by":"publisher","first-page":"e0130521","DOI":"10.1128\/Spectrum.01305-21","article-title":"Emergence of tigecycline nonsusceptible and IMP-4 carbapenemase-producing K2-ST65 hypervirulent Klebsiella pneumoniae in China","volume":"9","author":"Zhang","year":"2021","journal-title":"Microbiol Spectr"},{"key":"B86","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1007\/s11033-021-06307-y","article-title":"Mobilized colistin resistance (mcr) genes from 1 to 10: a comprehensive review","volume":"48","author":"Hussein","year":"2021","journal-title":"Mol Biol Rep"},{"key":"B87","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.jgar.2020.06.009","article-title":"Molecular mechanisms and prevalence of colistin resistance of Klebsiella pneumoniae in the Middle East region: a review over the last 5 years","volume":"22","author":"Aris","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"key":"B88","doi-asserted-by":"publisher","first-page":"109835","DOI":"10.1016\/j.ijfoodmicro.2022.109835","article-title":"First report from supermarket chicken meat and genomic characterization of colistin resistance mediated by mcr-1.1 in ESBL-producing, multidrug-resistant Salmonella Minnesota","volume":"379","author":"Habib","year":"2022","journal-title":"Int J Food Microbiol"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1244482\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T05:36:19Z","timestamp":1702013779000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1244482\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,7]]},"references-count":88,"alternative-id":["10.3389\/fpubh.2023.1244482"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2023.1244482","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,7]]},"article-number":"1244482"}}